Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

Blood Exposures Survey

The Association of Occupational Health Professionals in Healthcare (AOHP) recently commissioned a survey among its members to establish the first ...read more

Food Safety in Restaurants

Increased awareness and implementation of proper food safety in restaurants and delis may help prevent many of the foodborne illness outbreaks ...read more

Flu Facts

The Centers for Disease Control and Prevention (CDC) provides Frequently Asked Questions (FAQs) on key facts about the 2013-2014 influenza season. ...read more

SSI Prevention

This report explores the prevention of surgical site infections (SSIs) within the context of evidence-based practices replacing "sacred cows" in the ...read more

Biocides and Sporicidal Disinfectants

This Pulse provides a quick summary of some of the ideas and perspectives coming out of the 2013 Spring Conference of the Society of Healthcare ...read more

Latest Headlines

B. Braun Ultrasite Needle-Free IV System Designed to Help Prevent Exposure to Bloodborne Pathogens in the Radiology Suite

BETHLEHEM, Pa. -- B. Braun Medical Inc. announced today it has received U.S. FDA clearance for the use of its Ultrasite Needle-Free IV System with power injectors up to 300 psi, helping to prevent exposure to dangerous bloodborne pathogens in the radiology suite. B. Braun ...More
September 11, 2003 Posted in News
eMerge Begins Development of Human Hand Infection Control Scanning Device

SEBASTIAN, Fla. -- eMerge Interactive, Inc., a technology company providing food safety, individual-animal tracking and supply-procurement services to the beef-production industry announced that successful studies have led them to launch a product development program to ...More
September 11, 2003 Posted in News
NIAID Launches Malaria Vaccine Trial in Africa

WASHINGTON, D.C. -- The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has reached a milestone in its efforts to support accelerated development of malaria vaccines. Working with an international group of public and ...More
September 11, 2003 Posted in News
Maxxim Medical Signs Agreement to be Acquired by Lightyear Capital

OLDSMAR, Fla. -- Maxxim Medical, Inc., which filed for bankruptcy protection in February 2003, announced today that it has signed an agreement for the sale of substantially all of its assets and business to Lightyear Capital, a private equity investment firm that manages ...More
September 10, 2003 Posted in News
Joint Commission Resources Announces Availability of Staff Education Posters

OAKBROOK TERRACE, Ill. -- Joint Commission Resources (JCR) announces a new series of staff education posters focusing on patient safety issues. JCR is an affiliate of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). These 10 colorful posters help ...More
September 10, 2003 Posted in News
NIAID Opens Innovative Treatment Study for West Nile Virus

A clinical trial evaluating an experimental treatment for patients infected with West Nile virus (WNV) has begun enrolling volunteers at 36 sites nationwide, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, ...More
September 9, 2003 Posted in News
Updated AIDS Treatment Guidelines Recognize Growing Value and Importance of HIV Drug Resistance Testing

SOUTH SAN FRANCISCO, Calif. -- Recently updated guidelines from the International AIDS Society USA (IAS-USA) and the U.S. Department of Health and Human Services (DHHS) further support the value and importance of resistance testing as a means to improve virologic outcome ...More
September 9, 2003 Posted in News
Chimerix Awarded $36 Million NIH Grant to Develop Oral Drug for Treatment of Smallpox Infection

SAN DIEGO -- Chimerix Inc., an emerging biotechnology company developing orally available, targeted medicines from bioactive molecules, today announced that it has been awarded a four and a half year, $36.1 million grant from the U.S. National Institute of Allergy and ...More
September 9, 2003 Posted in News
Clinical Trial Shows Probactrix Effective for Treating Diarrhea Caused by Antibiotics

NEW YORK -- The BioBalance Corp., a wholly owned subsidiary of New York Health Care, today released the results of a randomized clinical study in which a formulation containing its proprietary biotherapeutic agent, Probactrix, appeared to rapidly and effectively control ...More
September 9, 2003 Posted in News
Air Quality Sciences' Experts to Present at Ground-Breaking Conference

ATLANTA, Ga. -- Air Quality Sciences (AQS) announced today that three of its experts will be taking part in the Fifth International Conference on Bioaerosols, Fungi, Bacteria, Mycotoxins and Human Health, to be held Sept. 10-12, 2003 in Saratoga Springs, N.Y. The conference ...More
September 8, 2003 Posted in News